Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Acne Vulgaris D000152 35 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenoma D000236 40 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia D000740 21 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Fabry Disease D000795 4 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Edema D004487 152 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Eye Abnormalities D005124 7 associated lipids
Fibrosis D005355 23 associated lipids
Glioblastoma D005909 27 associated lipids
Glioma D005910 112 associated lipids
Heart Failure D006333 36 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Influenza, Human D007251 11 associated lipids
Insulin Resistance D007333 99 associated lipids
Insulinoma D007340 28 associated lipids
Leukemia D007938 74 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Lung Neoplasms D008175 171 associated lipids
Melanoma D008545 69 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Cardiomyopathies D009202 10 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neuralgia D009437 28 associated lipids
Neuroblastoma D009447 66 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Ovarian Diseases D010049 5 associated lipids
Pain D010146 64 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Proteinuria D011507 30 associated lipids
Psoriasis D011565 47 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Retinal Detachment D012163 10 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Sarcoma 180 D012510 21 associated lipids
Sensation Disorders D012678 2 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Tuberculosis D014376 20 associated lipids
Vascular Diseases D014652 16 associated lipids
Reperfusion Injury D015427 65 associated lipids
Weight Gain D015430 101 associated lipids
Teratocarcinoma D018243 7 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Endotoxemia D019446 27 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Ileus D045823 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Lung Injury D055370 14 associated lipids
Acute Lung Injury D055371 33 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Radin NS Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come? 2001 Eur. J. Biochem. pmid:11168352
Siehler S et al. Sphingosine 1-phosphate activates nuclear factor-kappa B through Edg receptors. Activation through Edg-3 and Edg-5, but not Edg-1, in human embryonic kidney 293 cells. 2001 J. Biol. Chem. pmid:11673450
Cuvillier O and Levade T Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. 2001 Blood pmid:11675357
Tigyi G Selective ligands for lysophosphatidic acid receptor subtypes: gaining control over the endothelial differentiation gene family. 2001 Mol. Pharmacol. pmid:11723220
Castillo SS and Teegarden D Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells. 2001 J. Nutr. pmid:11694603
Lyons JM and Karin NJ A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells. 2001 J. Bone Miner. Res. pmid:11697799
Hornuss C et al. Human and rat alveolar macrophages express multiple EDG receptors. 2001 Eur. J. Pharmacol. pmid:11698050
Yoshida A and Ueda H Neurobiology of the Edg2 lysophosphatidic acid receptor. 2001 Jpn. J. Pharmacol. pmid:11700008
Im DS et al. Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): structure-activity relationship of sphingosine1-phosphate receptors. 2001 Biochemistry pmid:11705398
Rosenfeldt HM et al. The sphingosine-1-phosphate receptor EDG-1 is essential for platelet-derived growth factor-induced cell motility. 2001 Biochem. Soc. Trans. pmid:11709084
Ohmori T et al. G(i)-mediated Cas tyrosine phosphorylation in vascular endothelial cells stimulated with sphingosine 1-phosphate: possible involvement in cell motility enhancement in cooperation with Rho-mediated pathways. 2001 J. Biol. Chem. pmid:11056155
Malek RL et al. Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptors. 2001 J. Biol. Chem. pmid:11069896
Sullards MC and Merrill AH Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. 2001 Sci. STKE pmid:11752637
Okajima F [Establishment of the method for the measurement of sphingosine-1-phosphate in biological samples and its application for S1P research]. 2001 Nippon Yakurigaku Zasshi pmid:11778456
Hobson JP et al. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. 2001 Science pmid:11230698
Alderton F et al. Tethering of the platelet-derived growth factor beta receptor to G-protein-coupled receptors. A novel platform for integrative signaling by these receptor classes in mammalian cells. 2001 J. Biol. Chem. pmid:11359779
Pébay A et al. Antiproliferative properties of sphingosine-1-phosphate in human hepatic myofibroblasts. 2001 Eur. J. Neurosci. pmid:11422447
Kimura T et al. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. 2001 J. Biol. Chem. pmid:11427538
Ishii I et al. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. 2001 J. Biol. Chem. pmid:11443127
Kralik SF et al. A method for quantitative extraction of sphingosine 1-phosphate into organic solvent. 2001 Anal. Biochem. pmid:11444818
Wells CD et al. Identification of potential mechanisms for regulation of p115 RhoGEF through analysis of endogenous and mutant forms of the exchange factor. 2001 J. Biol. Chem. pmid:11384980
Liu F et al. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity. 2001 Am. J. Respir. Cell Mol. Biol. pmid:11415936
Olorundare OE et al. Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists. 2001 Blood pmid:11418470
Repp H et al. Activation of a Ca2+-dependent K+ current in mouse fibroblasts by sphingosine-1-phosphate involves the protein tyrosine kinase c-Src. 2001 Naunyn Schmiedebergs Arch. Pharmacol. pmid:11284444
Ruwisch L et al. An improved high-performance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials. 2001 Naunyn Schmiedebergs Arch. Pharmacol. pmid:11284453
Aas V et al. Fibronectin promotes calcium signaling by interferon-gamma in human neutrophils via G-protein and sphingosine kinase-dependent mechanisms. 2001 Cell Commun. Adhes. pmid:11936187
Tilly JL Emerging technologies to control oocyte apoptosis are finally treading on fertile ground. 2001 ScientificWorldJournal pmid:12805661
Nanjundan M and Possmayer F Characterization of the pulmonary N-ethylmaleimide-insensitive phosphatidate phosphohydrolase. 2000 Jul-Aug Exp. Lung Res. pmid:10914334
Olivera A et al. Assaying sphingosine kinase activity. 2000 Meth. Enzymol. pmid:10563328
Brindley DN et al. Analysis of ceramide 1-phosphate and sphingosine-1-phosphate phosphatase activities. 2000 Meth. Enzymol. pmid:10563330
Rümenapp U et al. Sphingolipid receptor signaling and function in human bladder carcinoma cells: inhibition of LPA- but enhancement of thrombin-stimulated cell motility. 2000 Naunyn Schmiedebergs Arch. Pharmacol. pmid:10651140
Lee OH et al. Sphingosine 1-phosphate stimulates tyrosine phosphorylation of focal adhesion kinase and chemotactic motility of endothelial cells via the G(i) protein-linked phospholipase C pathway. 2000 Biochem. Biophys. Res. Commun. pmid:10652210
Hla T et al. Sphingosine-1-phosphate signaling via the EDG-1 family of G-protein-coupled receptors. 2000 Ann. N. Y. Acad. Sci. pmid:10818438
Spiegel S Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein-coupled receptors. 2000 Ann. N. Y. Acad. Sci. pmid:10818441
Sato TN A new role of lipid receptors in vascular and cardiac morphogenesis. 2000 J. Clin. Invest. pmid:11032853
Liu Y et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. 2000 J. Clin. Invest. pmid:11032855
Xia P et al. An oncogenic role of sphingosine kinase. 2000 Curr. Biol. pmid:11114522
Okamoto H et al. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. 2000 Mol. Cell. Biol. pmid:11094076
Murata N et al. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. 2000 Biochem. J. pmid:11104690
Shimizu H et al. Sphingosine 1-phosphate stimulates insulin secretion in HIT-T 15 cells and mouse islets. 2000 Endocr. J. pmid:11036869
MacLennan AJ et al. Antisense studies in PC12 cells suggest a role for H218, a sphingosine 1-phosphate receptor, in growth-factor-induced cell-cell interaction and neurite outgrowth. 2000 Dev. Neurosci. pmid:10965150
Nakajima N et al. Expression and characterization of Edg-1 receptors in rat cardiomyocytes: calcium deregulation in response to sphingosine 1-phosphate. 2000 Eur. J. Biochem. pmid:10971577
Sugiyama A et al. Effects of sphingosine 1-phosphate, a naturally occurring biologically active lysophospholipid, on the rat cardiovascular system. 2000 Jpn. J. Pharmacol. pmid:10875754
Spiegel S and Milstien S Sphingosine-1-phosphate: signaling inside and out. 2000 FEBS Lett. pmid:10878250
Cooke ME et al. Contraction of collagen matrices mediated by alpha2beta1A and alpha(v)beta3 integrins. 2000 J. Cell. Sci. pmid:10852817
Yanai N et al. Sphingosine-1-phosphate and lysophosphatidic acid trigger invasion of primitive hematopoietic cells into stromal cell layers. 2000 Blood pmid:10891442
Prieschl EE and Baumruker T Beyond a structural component: sphingolipids in immunology. 2000 Arch. Immunol. Ther. Exp. (Warsz.) pmid:10912620
Ikeda H et al. Biological activities of novel lipid mediator sphingosine 1-phosphate in rat hepatic stellate cells. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10915638
Yamazaki Y et al. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway. 2000 Biochem. Biophys. Res. Commun. pmid:10679247
Lee H et al. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. 2000 Am. J. Physiol., Cell Physiol. pmid:10712250